{{Rsnum
|rsid=1123617
|Gene=SLC14A2
|Chromosome=18
|position=45672918
|Orientation=minus
|GMAF=0.1731
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC14A2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 70.8 | 27.4 | 1.8
| HCB | 43.1 | 43.1 | 13.9
| JPT | 59.3 | 33.6 | 7.1
| YRI | 91.2 | 8.8 | 0.0
| ASW | 75.4 | 24.6 | 0.0
| CHB | 43.1 | 43.1 | 13.9
| CHD | 52.3 | 39.4 | 8.3
| GIH | 66.3 | 26.7 | 6.9
| LWK | 82.7 | 16.4 | 0.9
| MEX | 60.3 | 37.9 | 1.7
| MKK | 76.3 | 21.2 | 2.6
| TSI | 67.6 | 30.4 | 2.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1123617
|Name_s=SLC14A2:Val227Ile
|Gene_s=SLC14A2
|Feature=
|Evidence=PubMed ID:17344938
|Annotation=In a Chinese population, this SNP was significantly associated with blood pressure response to nifedipine treatment.
|Drugs=nifedipine
|Drug Classes=
|Diseases=Hypertension
|Curation Level=Curated
|PharmGKB Accession ID=PA162316708
}}

{{GET Evidence
|gene=SLC14A2
|aa_change=Val750Ile
|aa_change_short=V750I
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1123617
|overall_frequency_n=1421
|overall_frequency_d=10758
|overall_frequency=0.132088
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=19
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.03
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}